The Health Information and Quality Authority (HIQA) has a statutory remit to evaluate the clinical and cost-effectiveness of health technologies, and provide advice to the Minister for Health and to the Health Service Executive (HSE). It is recognised that the findings of a HTA may have implications for other key stakeholders in the Irish healthcare system, such as patient groups, the general public, clinicians, other healthcare providers, academic groups, and the manufacturing industry.
HTA guideline documents provide an overview of the principles and methods used in assessing health technologies. The national HTA guidelines are intended as a guide for everyone who is involved in the conduct or use of HTA to inform decision-making in the publicly-funded health and social care system in Ireland. The purpose of the guidelines is to promote the production of assessments that are timely, reliable, consistent and relevant to the needs of decision-makers and key stakeholders in Ireland. HIQA is updating two national HTA guidelines and the draft reports are being made available for public consultation prior to being finalised:
- Guidelines for the Economic Evaluation of Health Technologies in Ireland
- Guidelines for the Budget Impact Analysis of Health Technologies in Ireland